Registry of Acute Coronary Syndrome in the Regional Cardiovascular Center

Active, not recruiting

• Conditions: Аcute Coronary Syndrome

• Registration Number: NCT06845384
• Lead Sponsor: National Medical Research Center for Therapy and Preventive Medicine

Brief Summary

The study is a prospective registry of patients consequently admitted to the regional cardiovascular center with a diagnosis of acute coronary syndrome, in order to study the behavior of patients from the first minutes of the onset of the anginal syndrome, and influence of the delay in calling of ambulance on short-term and long-term outcomes of the disease. Other factors which may influence short-term and long-term outcomes will also be assessed.

Detailed Description

Not available

Study Timeline

• Study Start: 2025-01-15
• Status Verified: 2025-02
• Study First Submitted: 2025-02-20
• Study First Submitted QC: 2025-02-20
• Study First Posted: 2025-02-25
• Last Update Submitted: 2025-02-26
• Last Update Posted: 2025-03-03
• Primary Completion: 2026-01-15
• Study Completion: 2026-01-15

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

1. Men and women aged 18 and over, permanently residing in the Moscow region and in Moscow.
2. Patients hospitalized in the Regional Vascular Center of Stupino Clinical Hospital (GBUZ MO SKB) with a diagnosis of ACS with and without ST-segment elevation.
3. Signing an informed consent form to participate in the study and the processing of personal data, as well as conducting a telephone survey during the follow-up.

Exclusion Criteria

1. The patient's refusal to participate in the study and to allow the use of personal data during the study.
2. The presence of mental illness.
3. The patient plans to leave Russia for permanent or long-term residence.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
all-cause mortality	1 year and 3 years

Secondary Outcome Measures

Name	Time	Method
Сombined secondary end-point	1 year and 3 years	Rate of nonfatal myocardial infarction, nonfatal stroke, hospitalization for decompensated heart failure, and emergency invasive cardiac interventions.

Trial Locations

Locations (1)

National Medical Research Centre for Therapy and Preventive Medicine; 🇷🇺 Moscow, Russian Federation